<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
	<channel>
		<title>Frost.com  - Healthcare Research</title>
		<link>http://www.frost.com/c/10024/home.do</link>
		<description> - Healthcare Research</description>
		<language>en-us</language>
		<item>
			<category>Market Insight</category>
			<title>Cloud Computing in European Healthcare IT - A Cost Effective Information Exchange Solution</title>
			<description>Cloud Computing is a term that denotes the use of hardware and software services that are delivered by service providers over a network of internet based computer systems which is commonly called the Cloud. Cloud computing allocates remote services with a user's software and data.</description>
			<link>http://www.frost.com/sublib/display-market-insight.do?id=278772942</link>
			<pubDate>Thu, 23 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-market-insight.do?id=278772942</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Rozw j rynku radiografii komputerowej i cyfrowej w Europie dzi&amp;#281;ki wy&amp;#380;szej jako&amp;#347;ci system w CR i DR</title>
			<description>Konieczno&amp;#347;&amp;#263; poprawy wydajno&amp;#347;ci i jako&amp;#347;ci bada&amp;#324; z u&amp;#380;yciem promieni radiograficznych staje si&amp;#281; bod&amp;#378;cem do coraz szerszego instalowania system w radiografii komputerowej</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278773163</link>
			<pubDate>Thu, 23 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278773163</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>&amp;#54532;&amp;#47196;&amp;#49828;&amp;#53944; &amp;#50532; &amp;#49444;&amp;#47532;&amp;#48264;, &amp;#49436;&amp;#50976;&amp;#47101; &amp;#48143; &amp;#48120;&amp;#44397; CRM &amp;#44592;&amp;#44592; &amp;#49884;&amp;#51109; &amp;#48516;&amp;#49437; &amp;#48372;&amp;#44256;&amp;#49436; &amp;#48156;&amp;#54364;</title>
			<description>&amp;#45817;&amp;#45544; &amp;#48143; &amp;#48708;&amp;#47564;&amp;#44284; &amp;#44057;&amp;#51008; &amp;#49457;&amp;#51064;&amp;#48337;&amp;#44284; &amp;#48512;&amp;#51221;&amp;#47589;, &amp;#49900;&amp;#48512;&amp;#51204;, &amp;#49900;&amp;#48169;&amp;#49464;&amp;#46041;&amp;#44284; &amp;#44057;&amp;#51008; &amp;#49900;&amp;#54792;&amp;#44288;&amp;#44228; &amp;#51656;&amp;#54872;&amp;#51032; &amp;#48156;&amp;#48337;&amp;#47456;&amp;#51060; &amp;#45458;&amp;#50500;&amp;#51648;&amp;#44256; &amp;#44256;&amp;#47161; &amp;#51064;&amp;#44396;&amp;#44032; &amp;#45720;&amp;#50612;&amp;#45224;&amp;#50640; &amp;#46384;&amp;#46972;, &amp;#50976;&amp;#47101;&amp;#44284; &amp;#48120;&amp;#44397; CRM(Cardiac Rhythm Management, &amp;#49900;&amp;#51109;&amp;#48149;&amp;#46041;&amp;#44288;&amp;#47532;) &amp;#44592;&amp;#44592;&amp;#50640; &amp;#45824;&amp;#54620; &amp;#54872;&amp;#51088;&amp;#52789;&amp;#51060; &amp;#54869;&amp;#45824;&amp;#46104;&amp;#44256; &amp;#51080;&amp;#45796;.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278764874</link>
			<pubDate>Wed, 22 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278764874</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Growing Cash Reserves Indicate Possibilities for Mergers and Acquisitions in Global Healthcare Technology Industry</title>
			<description>The healthcare technology industry is expected to become mature and stable by the end of Financial Year (FY) 2013, with an expanding net margin and steady Selling and General Administrative (SG&amp;A) expenses.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278766704</link>
			<pubDate>Wed, 22 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278766704</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets</title>
			<description>Healthcare organizations expanding into emerging markets like Brazil, Russia, India and China (BRIC) are realizing there are no shortcuts. </description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278664789</link>
			<pubDate>Tue, 21 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278664789</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Nano Bridging Molcules' Path-breaking Dental Implant Technology Receives 2013 Frost &amp; Sullivan Technology Innovation Leadership Award</title>
			<description>Based on its recent research on the dental implant market, Frost &amp; Sullivan presents Nano Bridging Molecules SA (NBM) with the 2013 European Frost &amp; Sullivan Award for Technology Innovation Leadership.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278712453</link>
			<pubDate>Tue, 21 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278712453</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>Vital Signs - HIMSS 2013 Annual Conference &amp; Exhibition</title>
			<description>This Special Edition issue of Vital Signs, released May 17, 2013, presents our review of the 2013 HIMSS Conference, recently held in New Orleans, LA. At HIMSS, various heath IT market participants come together to gain a comprehensive overview of the state of the health IT industry from the perspective of numerous and diverse stakeholders, including technology vendors, healthcare providers, academia, government and health policy leadership, and media. Frost &amp; Sullivan attended the event, and we present a summary of conference highlights, including major announcements; key findings and select excerpts from the 24th Annual HIMSS Leadership Survey; top trends impacting the health IT industry; and select vendor developments.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=9561-00-F6-00-00</link>
			<pubDate>Fri, 17 May 2013 14:15:39 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9561-00-F6-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. F508del Correctors To Target Cystic Fibrosis Transmembrane Regulator Gene Mutation; Anti-Cellulite Strategy Based on Mitochondrial Homeostasis of Adipocyte and Fibroblast</title>
			<description>This issue profiles F508del correctors to target cystic fibrosis transmembrane regulator gene mutation, an anti-cellulite strategy based on mitochondrial homeostasis of adipocyte and fibroblast, and an innovation in bioprocesses that enables improving metabolic engineering technologies.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-2C-00-00</link>
			<pubDate>Fri, 17 May 2013 06:56:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-2C-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Inside R&amp;D Alert. Achieving Nanotech Delivery Systems through Polyhedric Functionalized Nanoparticles; Closed-Loop System for Improved Tracking of Solar PV Systems; Reducing Rate of Precipitation In Biofuels Using High-Intensity Ultrasonic Energy</title>
			<description>This issue profiles achieving nanotech delivery systems through polyhedric functionalized nanoparticles, a closed-loop system for improved tracking of solar PV systems, and reducing rate of precipitation in biofuels using high-intensity ultrasonic energy.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D706-00-14-00-00</link>
			<pubDate>Fri, 17 May 2013 05:55:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D706-00-14-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Medical Device Technology Alert. Absorbable Polyurethane Technology for Biomedical Applications; Retinal Implant for Use in Patients with Retinitis Pigmentosa; Magnetic Implant Reduces Surgeries for Children with Severe Scoliosis</title>
			<description>This issue profiles absorbable polyurethane technology for biomedical applications, a retinal implant for use in patients with retinitis pigmentosa, and a magnetic implant that reduces surgeries for children with severe scoliosis.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D851-00-1A-00-00</link>
			<pubDate>Fri, 17 May 2013 05:08:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D851-00-1A-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>&amp;#1055;&amp;#1077;&amp;#1088;&amp;#1077;&amp;#1084;&amp;#1077;&amp;#1085;&amp;#1099; &amp;#1074; &amp;#1084;&amp;#1080;&amp;#1088;&amp;#1086;&amp;#1074;&amp;#1086;&amp;#1084; &amp;#1079;&amp;#1076;&amp;#1088;&amp;#1072;&amp;#1074;&amp;#1086;&amp;#1086;&amp;#1093;&amp;#1088;&amp;#1072;&amp;#1085;&amp;#1080;&amp;#1080;</title>
			<description>&amp;#1052;&amp;#1080;&amp;#1088;&amp;#1086;&amp;#1074;&amp;#1072;&amp;#1103; &amp;#1080;&amp;#1085;&amp;#1076;&amp;#1091;&amp;#1089;&amp;#1090;&amp;#1088;&amp;#1080;&amp;#1103; &amp;#1079;&amp;#1076;&amp;#1088;&amp;#1072;&amp;#1074;&amp;#1086;&amp;#1086;&amp;#1093;&amp;#1088;&amp;#1072;&amp;#1085;&amp;#1077;&amp;#1085;&amp;#1080;&amp;#1103; &amp;#1087;&amp;#1077;&amp;#1088;&amp;#1077;&amp;#1078;&amp;#1080;&amp;#1074;&amp;#1072;&amp;#1077;&amp;#1090; &amp;#1101;&amp;#1087;&amp;#1086;&amp;#1093;&amp;#1091; &amp;#1087;&amp;#1077;&amp;#1088;&amp;#1077;&amp;#1084;&amp;#1077;&amp;#1085;, &amp;#1088;&amp;#1072;&amp;#1079;&amp;#1083;&amp;#1080;&amp;#1095;&amp;#1085;&amp;#1099;&amp;#1077; &amp;#1089;&amp;#1077;&amp;#1075;&amp;#1084;&amp;#1077;&amp;#1085;&amp;#1090;&amp;#1099; &amp;#1101;&amp;#1090;&amp;#1086;&amp;#1075;&amp;#1086; &amp;#1088;&amp;#1099;&amp;#1085;&amp;#1082;&amp;#1072;, &amp;#1088;&amp;#1072;&amp;#1085;&amp;#1077;&amp;#1077; &amp;#1089;&amp;#1091;&amp;#1097;&amp;#1077;&amp;#1089;&amp;#1090;&amp;#1074;&amp;#1086;&amp;#1074;&amp;#1072;&amp;#1074;&amp;#1096;&amp;#1080;&amp;#1077; &amp;#1087;&amp;#1086;&amp;#1088;&amp;#1086;&amp;#1079;&amp;#1085;&amp;#1100;, &amp;#1089;&amp;#1077;&amp;#1075;&amp;#1086;&amp;#1076;&amp;#1085;&amp;#1103; &amp;#1089;&amp;#1083;&amp;#1080;&amp;#1074;&amp;#1072;&amp;#1102;&amp;#1090;&amp;#1089;&amp;#1103; &amp;#1074;&amp;#1086;&amp;#1077;&amp;#1076;&amp;#1080;&amp;#1085;&amp;#1086;, &amp;#1074;&amp;#1083;&amp;#1080;&amp;#1103;&amp;#1103; &amp;#1076;&amp;#1088;&amp;#1091;&amp;#1075; &amp;#1085;&amp;#1072; &amp;#1076;&amp;#1088;&amp;#1091;&amp;#1075;&amp;#1072;.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278455818</link>
			<pubDate>Thu, 16 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278455818</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Emerging Telehealth Markets Present Compelling Opportunities in Asia-Pacific</title>
			<description>Telehealth markets   comprising of telemedicine, remote patient monitoring and mhealth   present an important area of convergence for healthcare and information</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278390753</link>
			<pubDate>Wed, 15 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278390753</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Accolades Highlight Industry's Best-in-Class Performers</title>
			<description>Superlative achievements amongst over 20 companies delivering excellence in best practices across a broad spectrum of industries were celebrated at the Guoman Cumberland Hotel in London last Tuesday night.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278455679</link>
			<pubDate>Wed, 15 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278455679</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Emphasis on X-Ray Quality Spurs Adoption of Computed and Digital Radiography in Europe, Finds Frost &amp; Sullivan</title>
			<description>The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278335099</link>
			<pubDate>Tue, 14 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278335099</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Radiografia computerizzata e digitale: L'attenzione alla qualit  dei raggi X d  slancio mercato europeo, secondo Frost &amp; Sullivan</title>
			<description>Il bisogno di migliorare l'efficienza e la qualit  degli esami a raggi X porter  le strutture sanitarie in tutta Europa ad installare sistemi di radiografia computerizzata (CR) e radiografia digitale (DR). </description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278335438</link>
			<pubDate>Tue, 14 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278335438</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Cell Culture Purchasing Trends</title>
			<description>Basal media, fetal bovine media, and balanced salt solutions are prevalent cell culture media. However, serum free media and growth, as well as attachment factors, are expected to see increased use in 2013 because current non-users are planning to include them in their workflow.  Overall, Asia-Pacific is still a growing market in terms of the number of cell culture users, but high pricing and high usage rates make it a very attractive one. With respect to selection drivers, product consistency and having a past relationship with a supplier are the two key features that drive cell culture selection.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NBA3-01-00-00-00</link>
			<pubDate>Mon, 13 May 2013 13:09:17 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NBA3-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Insight</category>
			<title>New Models of Patient Engagement</title>
			<description></description>
			<link>http://www.frost.com/sublib/display-market-insight.do?id=278234322</link>
			<pubDate>Mon, 13 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-market-insight.do?id=278234322</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>A Rise in the Number of the Aged in Asia-Pacific Widens the Market for Home Care Devices, Finds Frost &amp; Sullivan</title>
			<description>Acknowledging the rapid aging of the population in Asia-Pacific, governments are encouraging patients to opt for home care by offering incentives, subsidies and tax cuts.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278234339</link>
			<pubDate>Mon, 13 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278234339</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Moving Beyond the Pill: Data Science to Impact Medicine More than the Drugs Themselves</title>
			<description>The global healthcare industry is in the middle of a massive remix, with disciplines merging and cross-pollinating.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278280355</link>
			<pubDate>Mon, 13 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278280355</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Recognizes Selventa's Proprietary Systems Diagnostics Technology Platform</title>
			<description>Based on its recent analysis of the systems diagnostics market, Frost &amp; Sullivan recognizes Selventa with the 2013 North America Frost &amp; Sullivan Award for Technology Leadership.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=278288237</link>
			<pubDate>Mon, 13 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=278288237</guid>
		</item>
		<item>
			<category>Customer Research</category>
			<title>U.S. Medical Imaging IT Middleware</title>
			<description>This is a repackaging of this research deliverable. During the fourth quarter of 2009, Frost &amp; Sullivan conducted a Customer Research project titled  Medical Imaging IT Middleware: A Study of Customer Perceptions and Purchase Intentions in the U.S. Hospital Market.  The study aimed to provide the vendors developing, selling, and implementing medical imaging IT middleware solutions with a sound basis to design and execute their growth strategies. Frost &amp; Sullivan targeted 160 U.S. department heads in radiology and cardiology, staff radiologists, clinicians, and hospital information systems administrators. This study utilized Frost &amp; Sullivan's Web-based survey capability. </description>
			<link>http://www.frost.com/sublib/display-report.do?id=NBD7-01-00-00-00</link>
			<pubDate>Fri, 10 May 2013 17:47:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NBD7-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Drug Discovery Technology Alert. Unraveling G-Protein Coupled Receptors and Complexes through Drug Screening Technology Platform; Synergizing Neurotherapeutics through Hybrid Cell-Based Microelectrode Array Platform</title>
			<description>This issue profiles unraveling G-protein coupled receptors and complexes through a drug screening technology platform, synergizing neurotherapeutics through a hybrid cell-based microelectrode array platform, and a synthetic virus-like particle platform technology that is capable of shaping next-generation vaccine development.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D950-00-4A-00-00</link>
			<pubDate>Fri, 10 May 2013 01:57:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D950-00-4A-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Promising Allergic Asthma Vaccine under Phase 2b Clinical Trial; Personalized Anti-Aging Product Recommendation Based on Rapid Genetic Testing</title>
			<description>This issue profiles a promising allergic asthma vaccine that is under phase 2b clinical trial, personalized anti-aging product recommendation based on rapid genetic testing, and a novel approach to mimic human cancer in vitro-chitosan-alginate-based scaffold system.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-2B-00-00</link>
			<pubDate>Fri, 10 May 2013 01:42:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-2B-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>Picture Archiving and Communication System Market Outlook in Malaysia</title>
			<description>Picture archiving and communication systems, commonly known as PACS, have only recently gained ground in the Malaysian healthcare delivery system. Given the comparatively small installed base in this country and the technology's need to be updated every 3 to 5 years, the Malaysian market presents significant opportunities for PACS vendors. This research service provides an overview of these opportunities by explaining the position of PACS in the 10th Malaysia Plan. Market drivers and restraints are presented in addition to select product, company, and distributor profiles. The base year is 2012.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=9837-00-5C-00-00</link>
			<pubDate>Thu, 9 May 2013 11:29:17 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9837-00-5C-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Chinese Pharmaceutical Market</title>
			<description>The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the market challenges and opportunities, competitive analysis, offers a revenue forecast, and a list of local company profiles along with their revenue.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P704-01-00-00-00</link>
			<pubDate>Thu, 9 May 2013 01:31:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P704-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Western European Endoscopy Devices Market</title>
			<description>The endoscopy devices market in Western Europe is growing due to the increase in minimally invasive surgical procedures. As the applicability of endoscopy devices increases, the market for these products is expected to register a steady revenue growth, despite the economic slowdown. The Western European endoscopy devices market can be segmented based on two criteria; one criterion is components and design, while the second criterion is applications.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=M8FC-01-00-00-00</link>
			<pubDate>Wed, 8 May 2013 23:54:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=M8FC-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Research Service</category>
			<title>Metabolomics--Newer 'Omics' to Analyse Biological Samples (Technical Insights)</title>
			<description>This report gives an overview of the metabolomics industry along with some of the technology trends in this space. The workflow along with developments and key companies have also been highlighted. Since a majority of developments in this space is stemming from intense R7D activities, the research networks and some of the technology management strategies adopted by developers (SMEs/Academia) and Tier1/2 companies has also been discussed. </description>
			<link>http://www.frost.com/sublib/display-report.do?id=D4DF-01-00-00-00</link>
			<pubDate>Wed, 8 May 2013 05:58:18 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D4DF-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the US Sterilization Equipment and Sterilants Market</title>
			<description>This research service considers products and companies in the sterilization equipment and sterilants market in the United States. The market will benefit from many technology improvements going forward. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market's various segments, including: steam sterilization, ethylene oxide sterilization, plasma sterilization and endoscope reprocessors. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market's competitive landscape. The base year is 2012, and the forecast period extends through 2017.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NC1B-01-00-00-00</link>
			<pubDate>Tue, 7 May 2013 10:54:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NC1B-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Demand for Hybrid Solutions to Spur European Interventional Radiology and Cardiology Markets, finds Frost &amp; Sullivan</title>
			<description>The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277970948</link>
			<pubDate>Tue, 7 May 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277970948</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Healthcare Landscape and Outlook in Turkey</title>
			<description>The study analyses the Turkish healthcare landscape, market outlook and growth opportunities by covering private healthcare services, pharmaceuticals, medical devices, medical imaging and clinical diagnostics segments. Rapid economic growth and healthcare transformation program generated a significant increase in healthcare expenditure in Turkey. The healthcare market in Turkey will witness more growth than mature markets, such as those in the United States, Japan and Europe. The research methodology of this study is based on primary interviews and secondary sources. The forecast period is 2011 2015.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=M8A5-01-00-00-00</link>
			<pubDate>Mon, 6 May 2013 01:00:09 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=M8A5-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Utilization of Splice-Switching Oligonucleotides To Alter Tumor Progression; Peptide Vaccine with Potential Anti-Angiogenic Effect To Treat Solid Tumors</title>
			<description>This issue profiles utilization of splice-switching oligonucleotides to alter tumor progression, a peptide vaccine with potential anti-angiogenic effect to treat solid tumors, and addressing acute liver failure as the prior step to liver transplantation.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-2A-00-00</link>
			<pubDate>Fri, 3 May 2013 06:31:45 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-2A-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the Global In Vitro Diagnostics Market</title>
			<description>Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost &amp; Sullivan's proprietary database of global research. Market segments include immunochemistry, self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), molecular diagnostics, hematology, clinical microbiology, and hemostasis. Regions include United States, Western Europe, Asia-Pacific, Latin America, and Eastern Europe. Each segment includes revenue forecasts for 2009 to 2017, market share, competitive landscape, and product analysis.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NC19-01-00-00-00</link>
			<pubDate>Thu, 2 May 2013 11:25:44 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NC19-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>Outsourcing to CMOs in Emerging Economies Boon or Bane?</title>
			<description>This article provides an outlook of the key trends which impact the global pharmaceutical and biotech contract manufacturing markets and analyses the pros and cons of outsourcing manufacturing processes to contract manufacturing organisations (CMOs) in emerging markets. Strategic recommendations for the success of CMOs have also been provided.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=9837-00-54-00-00</link>
			<pubDate>Tue, 30 Apr 2013 10:23:44 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9837-00-54-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan New Product Innovation Award Conferred on Protein Sciences Corporation for Flublok  Influenza Vaccine</title>
			<description>Based on its recent analysis of the influenza vaccines market, Frost &amp; Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277457158</link>
			<pubDate>Tue, 30 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277457158</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Acknowledges Euro Diagnostica AB s Excellence in Product Differentiation</title>
			<description>Based on its recent analysis of the autoimmune disease diagnostics market, Frost &amp; Sullivan recognises Euro Diagnostica AB with the 2013 Europe Product Differentiation Excellence Award.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277612781</link>
			<pubDate>Tue, 30 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277612781</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets, Says Frost &amp; Sullivan</title>
			<description>The limited efficacy and negative side-effects associated with current therapeutics for Hepatitis B and C are highlighting the urgent need for new, improved alternatives.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277658815</link>
			<pubDate>Tue, 30 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277658815</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the US General X-ray Imaging Equipment Market</title>
			<description>This research service analyzes the US general X-ray radiography imaging equipment market, which is transitioning toward more compact portable and modular digital technologies. The market segments evaluated are analog radiography, computed radiography (CR), and digital radiography (DR). The suites, mobiles, and retrofits sub-segments of the DR segment are also evaluated. Unit shipments, price, and revenue are estimated and forecasted for the 2009 to 2017 time period for each segment and sub-segment of the market. Other metrics including installed base, procedure volume, penetration rate, and market share are also estimated for 2012. An analysis of key market drivers and restraints is also provided.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NBBB-01-00-00-00</link>
			<pubDate>Mon, 29 Apr 2013 11:45:20 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NBBB-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Government Incentives Spur Adoption of Computed Tomography, Magnetic Resonance Imaging and Ultrasound Systems in Brazil, Finds Frost &amp; Sullivan</title>
			<description>Government programs and investments in Brazil's healthcare sector have lent momentum to the medical imaging market in the country. </description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277716944</link>
			<pubDate>Mon, 29 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277716944</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Medical and Diagnostic Imaging Technology Alert. Cardiac Imaging and Mapping Tool for Real-Time Analysis of Arrhythmias; Imaging System Developed To Monitor Brain Activity without Anesthesia; Microwave Tomography for Imaging Soft Tissues and Bones</title>
			<description>This issue profiles a cardiac imaging and mapping tool for real-time analysis of arrhythmias, an imaging system developed to monitor brain activity without anesthesia, and microwave tomography for imaging soft tissues and bones.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D860-00-6A-00-00</link>
			<pubDate>Fri, 26 Apr 2013 07:27:36 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D860-00-6A-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Inside R&amp;D Alert. Reducing Warping of Solar Cell Elements in a Concentrated Solar Power System; Cloud Contact Center with an Interactive Platform; Potential of Silica-Coated Pectinate Beads for Controlled-Release of Drug Delivery</title>
			<description>This issue profiles reducing warping of solar cell elements in a concentrated solar power system, a cloud contact center with an interactive platform, and potential of silica-coated pectinate beads for controlled-release of drug delivery.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D706-00-11-00-00</link>
			<pubDate>Fri, 26 Apr 2013 06:40:36 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D706-00-11-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Study of Adult Genome s Correlated Biological Role in Dental Caries; Visual Cycle Modulation Therapy To Treat Dry-AMD; Building Synthetic Modular Human Monoclonal Antibody Libraries on Miniaturized Devices</title>
			<description>This issue profiles the study of adult genome's correlated biological role in dental caries, visual cycle modulation therapy to treat dry-AMD, and building synthetic modular human monoclonal antibody libraries on miniaturized devices.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-29-00-00</link>
			<pubDate>Fri, 26 Apr 2013 04:36:36 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-29-00-00</guid>
		</item>
		<item>
			<category>Market Insight</category>
			<title>Radio Frequency Identification (RFID) in the Healthcare Industry</title>
			<description>Studies have indicated that the healthcare industry is faced with numerous challenges that result in monetary losses. </description>
			<link>http://www.frost.com/sublib/display-market-insight.do?id=277457280</link>
			<pubDate>Fri, 26 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-market-insight.do?id=277457280</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Asia-Pacific Hospital Outlook 2013</title>
			<description>This research service presents an outlook of the hospital industry in Asia-Pacific. It provides an analysis of demographic indicators, healthcare infrastructure, market dynamics, medical tourism, key trends, and opportunities in the Asia-Pacific market. The private segment in the APAC hospital industry is attracting several healthcare and non-healthcare investors to capitalize on the opportunity, as the market is set to grow at a rate of 19 percent over the next five years.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P6FE-01-00-00-00</link>
			<pubDate>Thu, 25 Apr 2013 00:25:48 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P6FE-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: India s Vast Mobile User Base makes it an Ideal Market for mHealth Services</title>
			<description>Changing disease profiles, increased adoption of smart phones, advancements in mobile technology, and greater focus on health and wellness are laying concrete foundation for mHealth in India.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277403220</link>
			<pubDate>Thu, 25 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277403220</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>&amp;#1055;&amp;#1088;&amp;#1077;&amp;#1087;&amp;#1072;&amp;#1088;&amp;#1072;&amp;#1090;&amp;#1099; &amp;#1076;&amp;#1083;&amp;#1103; &amp;#1083;&amp;#1077;&amp;#1095;&amp;#1077;&amp;#1085;&amp;#1080;&amp;#1103; &amp;#1042;&amp;#1048;&amp;#1063; &amp;#1074; &amp;#1045;&amp;#1074;&amp;#1088;&amp;#1086;&amp;#1087;&amp;#1077;</title>
			<description>&amp;#1086;&amp;#1078;&amp;#1080;&amp;#1076;&amp;#1072;&amp;#1077;&amp;#1084;&amp;#1099;&amp;#1081; &amp;#1074;&amp;#1099;&amp;#1074;&amp;#1086;&amp;#1076; &amp;#1085;&amp;#1072; &amp;#1088;&amp;#1099;&amp;#1085;&amp;#1086;&amp;#1082; &amp;#1085;&amp;#1086;&amp;#1074;&amp;#1099;&amp;#1093; &amp;#1083;&amp;#1077;&amp;#1082;&amp;#1072;&amp;#1088;&amp;#1089;&amp;#1090;&amp;#1074;&amp;#1077;&amp;#1085;&amp;#1085;&amp;#1099;&amp;#1093; &amp;#1089;&amp;#1088;&amp;#1077;&amp;#1076;&amp;#1089;&amp;#1090;&amp;#1074;, &amp;#1072; &amp;#1090;&amp;#1072;&amp;#1082;&amp;#1078;&amp;#1077; &amp;#1087;&amp;#1077;&amp;#1088;&amp;#1086;&amp;#1088;&amp;#1072;&amp;#1083;&amp;#1100;&amp;#1085;&amp;#1086; &amp;#1087;&amp;#1088;&amp;#1080;&amp;#1085;&amp;#1080;&amp;#1084;&amp;#1072;&amp;#1077;&amp;#1084;&amp;#1099;&amp;#1093;</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277456098</link>
			<pubDate>Thu, 25 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277456098</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: More than 10 Million U.S. Patients Treatable by Neurostimulation, Driving Uptake</title>
			<description>The neurostimulation device market in the United States is poised for rapid growth as increasing patient dissatisfaction with conventional therapies spurs demand for alternative, less-invasive treatment solutions.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277342941</link>
			<pubDate>Wed, 24 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277342941</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Healthcare Landscape, Outlook, and Growth Opportunities in India</title>
			<description>The healthcare market in India is in a growth stage and the growth rate is as high as any other fast-growing markets in the country. Moreover, the healthcare market is expected to drive the economy in the coming years. The main factors driving the growth are rising population, change in demographics, rise in disposable income, change in disease profile, rise in health insurance, and rise in medical tourism.Such high growth is resulting in a number of challenges for this market as it is a supply- constrained market and is facing a severe shortage of infrastructure, human resource, health insurance, health expenditure, and so on</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P6B6-03-00-00-00</link>
			<pubDate>Tue, 23 Apr 2013 07:33:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P6B6-03-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Image-guided and Robot-assisted Surgery Markets in Western Europe Set for Strong Expansion, says Frost &amp; Sullivan</title>
			<description>Image-guided and robot-assisted surgeries have made successful inroads into the western European market.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277300075</link>
			<pubDate>Tue, 23 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277300075</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Government Initiatives Drive Use of Electronic Medical and Health Records in Asia-Pacific</title>
			<description>Electronic medical record (EMR) and electronic health record (EHR) systems are becoming increasingly popular in Asia-Pacific as the region's healthcare industry moves towards digitization.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277300532</link>
			<pubDate>Tue, 23 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277300532</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Company of the Year Award Conferred on Medtech SAS</title>
			<description>Based on its recent analysis of the surgical robotics for neurosurgical interventions market, Frost &amp; Sullivan recognises Medtech SAS with the prestigious 2013 European Company of the Year Award.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277248064</link>
			<pubDate>Mon, 22 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277248064</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>The Role of Mobile Network Operators in Healthcare Delivery in Central and Eastern Europe</title>
			<description>Healthcare systems across Europe face a number of challenges that call for a rapid change in the delivery of healthcare services. Mobile network operators can play a significant role in the transformation of healthcare. Although the mobile health (mHealth) market is still nascent, we can observe some interesting initiatives, also in Central and Eastern Europe (CEE). This study in the first part gives an overview of mobile health solutions and the market situation in CEE. In the second section, a drivers and restraints analysis is conducted, alongside an estimation of mobile health revenue model for CEE. This is followed by a detailed listing of the mHealth solutions offered by the region's major mobile operators. </description>
			<link>http://www.frost.com/sublib/display-report.do?id=9A68-00-09-00-00</link>
			<pubDate>Fri, 19 Apr 2013 12:19:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9A68-00-09-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the South African Medical Imaging Market</title>
			<description>This research service presents the findings on the South African Medical Imaging Market. The research service presents an overview of the healthcare and medical imaging industry structure of the country. The market size and growth of the total medical imaging market, including five main device segments that characterise the market are presented. A comprehensive competitor overview is provided for the total market, as well as on a segment level. Insight into the market dynamics, particularly drivers and restraints, as well as forecast and trend analysis for the total market are provided in this research service. The study period is from 2011 to 20118.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=M901-01-00-00-00</link>
			<pubDate>Fri, 19 Apr 2013 08:56:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=M901-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Medical Device Technology Alert. Retroreflector Technology Deployed To Detect Infectious Diseases; Tissue Engineering Platform Finds Increased Usage in Performing ACL Reconstruction Surgeries; Vertebral Augmentation System for Repair of Spinal Fractures</title>
			<description>This issue profiles retroreflector technology deployed to detect infectious diseases, a tissue engineering platform that finds increased usage in performing anterior crucial ligament reconstruction surgeries, and a vertebral augmentation system for repair of spinal fractures.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D851-00-19-00-00</link>
			<pubDate>Fri, 19 Apr 2013 04:00:17 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D851-00-19-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. HPV Test Based on Urine Analysis; Gene Biomarkers Linked To Scleroderma Personalized Therapy Discovered; Targeted ADAM 17 and EFGR To Treat Dermal Fibrosis</title>
			<description>This issue profiles a HPV test based on urine analysis, discovery of the link between gene biomarkers and scleroderma personalized therapy, and using targeted ADAM 17 and EFGR to treat dermal fibrosis.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-28-00-00</link>
			<pubDate>Fri, 19 Apr 2013 01:40:16 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-28-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Confers 2013 South Africa Market Share Leadership Award on Shimadzu Corporation</title>
			<description>Based on its recent analysis of the general X-ray devices market, Frost &amp; Sullivan recognises Shimadzu Corporation with the 2013 South Africa Market Share Leadership Award.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277048113</link>
			<pubDate>Thu, 18 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277048113</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan : De nouveaux m dicaments tr s prometteurs pour le march  europ en des traitements anti-VIH</title>
			<description>De nouveaux m dicaments et l'introduction des comprim s combin s devraient avoir un impact profond sur le march  europ en des traitements anti-VIH.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=277048179</link>
			<pubDate>Thu, 18 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=277048179</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Growing Reimbursement Challenges Force Hospitals to Reengineer Revenue Cycle Management</title>
			<description>Today, hospitals are facing the twin burdens of Medicare and Medicaid cuts stipulated by the Affordable Care Act (ACA)   estimated at more than $150 billion in reductions over the next 10 years   in addition to the specter of additional cuts from the Budget Control Act of 2011.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276992386</link>
			<pubDate>Wed, 17 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276992386</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Promise of Cost-effective Healthcare Delivery to Boost Remote Patient Monitoring Market, Says Frost &amp; Sullivan</title>
			<description>Remote patient monitoring (RPM) technologies help patients retain their independence and avert further health complications. These technologies can also be a vital tool for governments to curb spiralling healthcare expenditures.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276993354</link>
			<pubDate>Wed, 17 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276993354</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the Asia-Pacific Molecular Diagnostics Market</title>
			<description>This Market Engineering research services is to analyze and evaluate the molecular diagnostics market in the Asia-Pacific region. This research covers four segments, namely infectious diseases, genetic diseases, oncology, and pharmacogenomics. It provides insights and analysis on current and future trends, market drivers, market restraints, revenue forecast, competitive analysis, and the market share of key participants in this market. This research service also presents the country analysis of selected emerging markets in Asia-Pacific to explore the challenges and opportunities in this market.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P6F6-01-00-00-00</link>
			<pubDate>Tue, 16 Apr 2013 11:58:15 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P6F6-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Research Service</category>
			<title>Top Technologies in Sensors and Control (Technical Insights)</title>
			<description>This research service covers key sensor applications in the sensors and control cluster. Applications enabled by advanced sensor technologies that are bound to have high impact in the near-term and medium-term are captured in the research service. It also covers various dimensions that shape sensors market such as year of impact and market opportunities; technology adoption status; and market impact of key innovations. The research service also covers the breadth of industries benefited by such sensors.  Funding trends, megatrend impact and potential points of convergence are also covered to provide a complete view of the sensor applications and their impact on the intended market.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D4E6-01-00-00-00</link>
			<pubDate>Tue, 16 Apr 2013 07:47:20 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D4E6-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market</title>
			<description>The anticipated launch of drugs currently in the pipeline, together with the introduction of oral combination pills, are set to have a profound impact on the European HIV drugs market.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276942506</link>
			<pubDate>Tue, 16 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276942506</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Mercato europeo dei nuovi farmaci per l'HIV in crescita, secondo Frost &amp; Sullivan</title>
			<description>Il lancio previsto di farmaci attualmente in fase di sviluppo, insieme all'introduzione di pillole combinate, avranno un profondo impatto sul mercato europeo dei farmaci per l'HIV.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276942580</link>
			<pubDate>Tue, 16 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276942580</guid>
		</item>
		<item>
			<category>Technical Insights Research Service</category>
			<title>2013 Top Medical Device and Imaging Technologies (Technical Insights)</title>
			<description>The research service titled  Top Medical Device and Imaging Technologies , is an update on the study done in the past year (D2F9 Top Medical Device and Imaging Technologies) that showcased medical technologies on the cusp of commercialization, both device and imaging centric, which hold the potential to possibly revolutionize the healthcare landscape in the next 3 to 4 years. The study still retains the same tone as 2012, with technologies profiled and selected based on the following criteria unmet market need, portability, ease of use and form factor; ionizing and non-ionizing; minimally invasive/non-invasive  techniques, cost and time savings.  </description>
			<link>http://www.frost.com/sublib/display-report.do?id=D4DD-01-00-00-00</link>
			<pubDate>Mon, 15 Apr 2013 06:57:40 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D4DD-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Drug Discovery Technology Alert. Enhanced Genotoxicity Platform for Drug Discovery and Environment Biomonitoring; Avoiding Multi-Drug Resistance through Antibacterial Drug Discovery Platform</title>
			<description>This issue profiles an enhanced genotoxicity platform for drug discovery and environment biomonitoring, avoiding multi-drug resistance through antibacterial drug discovery platform, and addressing familial Alzheimer's Disease through stem cell-based drug discovery platform.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D950-00-49-00-00</link>
			<pubDate>Fri, 12 Apr 2013 02:28:34 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D950-00-49-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Tissue Engineering of Adipogenic Hydrogel and Investigation of its Adipogenesis Properties; Genetic Links for Childhood Obesity Identified; CRTH2 Antagonist for Treatment of Allergic Asthma</title>
			<description>This issue profiles tissue engineering of adipogenic hydrogel and investigation of its adipogenesis properties, identification of genetic links for childhood obesity, and a CRTH2 antagonist for treatment of allergic asthma.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-27-00-00</link>
			<pubDate>Fri, 12 Apr 2013 01:12:20 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-27-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market</title>
			<description>This research service pertains to the US market for interventional x-ray equipment used in radiology and cardiology. A thorough market sizing and forecasting model of market revenue, unit shipments, and pricing is included, along with analyses of technology trends, market drivers and restraints, and the competitive environment. The two market segments considered are interventional radiology (IR) and interventional cardiology (IC). The study also covers clinical specialties utilizing high-end interventional x-ray equipment, such as neurology and oncology. The base year of the study is 2012; the forecast period extends through 2019.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NC13-01-00-00-00</link>
			<pubDate>Wed, 10 Apr 2013 12:24:05 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NC13-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?</title>
			<description>This market insight provides an in-depth understanding of the key drivers and challenges that impact the growth of the European biopharmceutical contract manufacturing market. An overview of the key biologics in various phases of clinical pipeline as well as the manufacturing capacity demand forecasts have been provided. A snapshot of the competitive structure and the future directions and trends in the European biopharmaceutical contract manufacturing market have been discussed. </description>
			<link>http://www.frost.com/sublib/display-report.do?id=9837-00-31-00-00</link>
			<pubDate>Tue, 9 Apr 2013 11:04:33 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9837-00-31-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Private and Public Sector Collaboration is Critical for Women's Health Market to Truly Flourish</title>
			<description>Venture capital (VC) firms are increasingly turning their attention to women's health, the primary area of focus being breast cancer research. However, there is a slow but steady widening in focus to embrace new pathologies</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276588770</link>
			<pubDate>Tue, 9 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276588770</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost &amp; Sullivan</title>
			<description>The rise in the number of minimally invasive surgeries (MIS) is promoting the use of endoscopy devices. These devices provide the necessary visualisation during MIS procedures.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276589902</link>
			<pubDate>Tue, 9 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276589902</guid>
		</item>
		<item>
			<category>Technical Insights Research Service</category>
			<title>Trends in Nanofluidics and BioNEMS (Technical Insights)</title>
			<description>Nanobiotechnologies play a preponderant role in the present and future of the lifesciences and biotech industry. In this research service, Frost &amp; Sullivan has focused on Nanofluidics and BioNanoElectroMechanicalSystems-BioNEMS. This novel discipline involves the study of fluids flowing through nanoscale channels and pores, while leveraging physicochemical aspects for measuring and screening purposes. This RS aims to cover the principal aspects associated with the nanobiotechnology landscape and its main trends and opportunities through 9 criteria:  
1 Year of Impact 
2 Market Potential 
3 Global Footprint 
4 IP Intensity 
5 Funding 
6 Breadth of Industries 
7 Megatrend Impact 
8 Potential Points of Convergence 
9 Size of Innovation Ecosystem</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D4CC-01-00-00-00</link>
			<pubDate>Mon, 8 Apr 2013 07:10:45 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D4CC-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan: Rapid Technological Advancements will Transform Healthcare Delivery in Asia-Pacific over the Next Decade</title>
			<description>The healthcare industry in Asia-Pacific is undergoing a transformation under the influence of an evolving consumer profile, dynamic disease patterns and increasing healthcare costs.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276544956</link>
			<pubDate>Mon, 8 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276544956</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>U.S. Hospital Revenue Cycle Management</title>
			<description>This study provides a roadmap for understanding the hospital revenue management (RCM) market. Herein Frost &amp; Sullivan provides an in-depth overview of the market including major government initiatives driving changes in the market, defines and describes major market segments including technology solutions and services used by hospitals, discusses the competitive market structure including business models and pricing approaches, and reviews key market considerations and strategic imperatives relevant to a variety of stakeholders including IT vendors. Market forecasts are provided for the total market as well as key market segments for 2012 through 2017. Also provided are brief profiles of 12 technology vendors serving the market.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NB9C-01-00-00-00</link>
			<pubDate>Fri, 5 Apr 2013 11:30:46 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NB9C-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Healthcare Information Technology Market Outlook in India</title>
			<description>The study gives an overview of the Indian healthcare market and its socio-demographic factors. The study examines, explains, and provides forecasts for the healthcare market and healthcare IT market expenditure with a focus on electronic medical records, clinical systems and non-clinical systems. It also provides chief information technology officer and vendor insight about healthcare IT solutions used in hospitals. The study identifies the major restraints, drivers, and challenges, and their effects on the healthcare IT market in the future. The study concludes with detail on priorities, opportunities, and insight as mentioned by the vendors and the chief information technology officers.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P67B-01-00-00-00</link>
			<pubDate>Fri, 5 Apr 2013 09:40:46 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P67B-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Market Trends in Interventional Radiology and Cardiology in Europe</title>
			<description>This research service provides an analysis of various aspects of the interventional radiology and cardiology market in Europe between 2011 and 2017. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, Scandinavia, Spain and the United Kingdom. A detailed analysis of prices, revenues and unit shipment has been presented, both at the total market level and at the country level. The research service highlights the main drivers and restraints for market growth as well as key technology and market trends in the interventional radiology and cardiology market between 2012 and 2017.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=M928-01-00-00-00</link>
			<pubDate>Fri, 5 Apr 2013 01:32:46 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=M928-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Immunomodulation Strategy by Immunostimulatory Sequences To Target Toll-Like Receptor-9; Genetic Risk Factors for Ovarian Cancer Identified</title>
			<description>This issue profiles immunomodulation strategy by immunostimulatory sequences to target toll-like receptor-9, cell cycle proteins trafficking and their association with beta cell replication discovered, and discovery of genetic risk factors for ovarian cancer.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-26-00-00</link>
			<pubDate>Fri, 5 Apr 2013 00:03:46 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-26-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>U.S. qPCR Reagents Market</title>
			<description>This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due to a period of patent expirations, competitive expansion, and pricing pressure. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive landscape, revenue forecasts, and the important trends affecting growth. Further discussed are selected end-user data on qPCR reagents usage, researchers' desired workflow improvements, and details on detection chemistries and assays utilized. Lastly, this analysis presents major market dynamics and strategic recommendations for competitors.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NBE1-01-00-00-00</link>
			<pubDate>Thu, 4 Apr 2013 10:34:45 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NBE1-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Telehealth Opportunities in APAC</title>
			<description>Telehealth refers to the utilization of advanced communication technologies to deliver care at a distance. The very ambiguity in its definition lends telehealth its broad scope. There are several markets and segments emerging in Asia-Pacific that aim to deliver healthcare and wellness services at a distance. However, all stakeholders within the telehealth ecosystem - healthcare providers, consumers, government bodies, vendors, and infrastructure developers - are grappling with optimum, sustainable business models. This study aims to identify some innovative, successful business models and share best practices and key learnings from such initiatives. </description>
			<link>http://www.frost.com/sublib/display-report.do?id=P6ED-01-00-00-00</link>
			<pubDate>Thu, 4 Apr 2013 05:22:45 +0100</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P6ED-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>&amp;#54532;&amp;#47196;&amp;#49828;&amp;#53944; &amp;#50532; &amp;#49444;&amp;#47532;&amp;#48264;, &amp;#50976;&amp;#47101; &amp;#48516;&amp;#51088;&amp;#50689;&amp;#49345; &amp;#49884;&amp;#51109; &amp;#48516;&amp;#49437; &amp;#48372;&amp;#44256;&amp;#49436; &amp;#48156;&amp;#54364;</title>
			<description>&amp;#48516;&amp;#51088;&amp;#50689;&amp;#49345; &amp;#51076;&amp;#49345;&amp;#51025;&amp;#50857;&amp;#50640;&amp;#49436; &amp;#51333;&amp;#50577;&amp;#54617;, &amp;#49900;&amp;#51109;&amp;#54617;&amp;#50640; &amp;#51060;&amp;#50612; &amp;#44032;&amp;#51109; &amp;#51452;&amp;#47785; &amp;#48155;&amp;#51012; &amp;#45796;&amp;#51020; &amp;#51032;&amp;#54617;&amp;#51004;&amp;#47196; &amp;#49888;&amp;#44221;&amp;#54617;&amp;#51060; &amp;#44861;&amp;#55176;&amp;#44256; &amp;#51080;&amp;#45796;.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276287755</link>
			<pubDate>Wed, 3 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276287755</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Healthcare's Evolution to 2025: Personalization, Without a Primary Care Physician</title>
			<description>The adoption of the accountable care organization (ACO) model is changing the way hospitals evaluate their structure, roles, activities and benchmarks.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276193087</link>
			<pubDate>Tue, 2 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276193087</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Will Brazil, Russia, India and China Ever Become the Golden Goose of the Future for Life Science and Medical Device Companies?</title>
			<description>Multinational firms have been exploring opportunities in emerging markets as a strategy to face the Western slowdown. However, after facing limited growth in these regions during 2012</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276193213</link>
			<pubDate>Tue, 2 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276193213</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>On-demand Webinar: Top Five Growth Sectors in the Asia-Pacific Healthcare Market</title>
			<description>While global healthcare markets are forecast to grow at a less than 6 percent compound annual growth rate (CAGR) from 2012 to 2018</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276193296</link>
			<pubDate>Tue, 2 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276193296</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Frost &amp; Sullivan Forecasts Robust Future for European Health Information Exchange Market</title>
			<description>The European market for health information exchange is diverse, with different IT vendors supporting the process of information exchange at different levels.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=276289104</link>
			<pubDate>Tue, 2 Apr 2013 00:00:00 +0100</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=276289104</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>EMR and EHR Market in APAC</title>
			<description>The Asia-Pacific (APAC) market for Electronic Medical Records (EMRs) and Electronic Health Records (EHRs) is in the growth phase with healthcare providers rapidly moving towards digitization. Governments across APAC are investing in EMR and EHR pilots and pushing for national level EHRs, and this is acting as the main driver for market growth. 
 This research service from Frost &amp; Sullivan analyzes the key drivers, restraints, technology trends, and buying behaviour characteristic of the EMR and EHR market in APAC and presents insights on revenue, market shares, and emerging opportunities in the industry. 
</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P6F9-01-00-00-00</link>
			<pubDate>Sat, 30 Mar 2013 08:54:29 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P6F9-01-00-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>High-Tech Materials Alert. Vanadium Oxide-Graphene Ribbons as Cathodes for Ultrafast Secondary Batteries; Metal-Doped Carbon Gel Enables Reduction of Carbon Dioxide Emissions; Adoption of Polymeric Materials in Skeletal Medical Implants</title>
			<description>This issue profiles use of vanadium oxide-graphene ribbons as cathodes for ultrafast secondary batteries, a metal-doped carbon gel that enables reduction of carbon dioxide emissions, and adoption of polymeric materials in skeletal medical implants.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D736-00-15-00-00</link>
			<pubDate>Fri, 29 Mar 2013 02:35:47 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D736-00-15-00-00</guid>
		</item>
		<item>
			<category>Technical Insights Alert</category>
			<title>Genetic Technology Alert. Accurate and Non-Invasive Colon Cancer Screening Test; ADAM-10 as Possible Target for Treatment of Angiogenesis in Rheumatoid Arthritis; miRNA Biomarker Linked with Atherosclerosis Initiation Discovered</title>
			<description>This issue profiles an accurate and non-invasive colon cancer screening test; using ADAM-10 as possible target for treatment of angiogenesis in rheumatoid arthritis, discovery of  miRNA biomarker's link with atherosclerosis initiation.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=D756-00-25-00-00</link>
			<pubDate>Fri, 29 Mar 2013 00:31:46 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=D756-00-25-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Brazilian Medical Imaging Market Outlook for CT, MRI, and Ultrasound</title>
			<description>This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the 'C'-class economic growth that allows increased access to healthcare services. The market is also propelled by government public health policies focused on decreasing the difference between the medical imaging equipment per capita rates among the states of Brazil. The Brazilian medical imaging analysis includes unit shipment, revenues, installed base, and replacement forecasts for the total market and for each modality analyzed.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=NBBF-01-00-00-00</link>
			<pubDate>Thu, 28 Mar 2013 09:59:10 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=NBBF-01-00-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>Healthcare Infrastructure: Market for New and Revitalized Hospitals in Kenya </title>
			<description>The aim of this research service was to provide insight into the market for revitalization and construction of new hospitals in the country and in addition quantify this market. This research service provides a detailed overview of the structure of the public and private hospital sector in Kenya. An overview of the healthcare structure as well as healthcare financing and expenditure in Kenya is also provided. This research furthermore analyses the drivers, restraints and dynamics in the hospital construction market and concludes by making predictions for the hospital construction market in Kenya.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=9837-00-5B-00-00</link>
			<pubDate>Wed, 27 Mar 2013 10:32:47 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9837-00-5B-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Advances in Surgical Technologies Boost Demand for Efficient Bone Graft Substitutes, Finds Frost &amp; Sullivan</title>
			<description>Product and technology improvements in healthcare increased the number of orthopedic surgeries and subsequently, the demand for efficacious bone graft materials in the United States.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=275897178</link>
			<pubDate>Wed, 27 Mar 2013 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=275897178</guid>
		</item>
		<item>
			<category>Market Engineering Research</category>
			<title>Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS </title>
			<description>This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS.  A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and HIV infection.  Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=9837-00-57-00-00</link>
			<pubDate>Tue, 26 Mar 2013 09:58:51 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=9837-00-57-00-00</guid>
		</item>
		<item>
			<category>Market Engineering Research Service</category>
			<title>Analysis of the Asia-Pacific Home Care Devices Market</title>
			<description>The purpose of this research service is to analyze the market trends and revenue opportunities for home care devices in the Asia-Pacific (APAC) countries of Australia, South Korea, Malaysia, Indonesia, India, China, Japan, Singapore, Thailand, and Vietnam. The study comprises the following segments: mobility aids, incontinence management, respiratory devices, and IV therapy devices used in home care setting. It discusses market drivers, market restraints, long term care setting, and reimbursement or insurance coverage for home care devices in these countries.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=P65F-01-00-00-00</link>
			<pubDate>Tue, 26 Mar 2013 04:01:47 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=P65F-01-00-00-00</guid>
		</item>
		<item>
			<category>Best Practices Research</category>
			<title>Frost &amp; Sullivan Awards for Bio-Synthetic Materials for Prosthetic limbs (Technical Insights) </title>
			<description>This Frost &amp; Sullivan award provides a detailed insight into the latest global developments in the field of bio-synthetic materials for prosthetic limbs.</description>
			<link>http://www.frost.com/sublib/display-report.do?id=I4C9-01-00-00-00</link>
			<pubDate>Tue, 26 Mar 2013 00:24:43 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-report.do?id=I4C9-01-00-00-00</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Interventional Radiology and Cardiology Treatment Methods Find Newer Markets in Asia-Pacific, Finds Frost &amp; Sullivan</title>
			<description>The growing number of aging people, along with the high incidence of cardiovascular and cerebrovascular diseases in Asia-Pacific due to unhealthy lifestyles</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=275888886</link>
			<pubDate>Tue, 26 Mar 2013 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=275888886</guid>
		</item>
		<item>
			<category>Press Release</category>
			<title>Competitive Pricing Vital in the Asia-Pacific Digital and Computed Radiography Market, Finds Frost &amp; Sullivan</title>
			<description>Healthcare delivery and service markets in Asia-Pacific are increasingly focusing on radiography systems that bundle the benefits of reduced radiation, seamless workflow, safety measures, and attractive pricing.</description>
			<link>http://www.frost.com/prod/servlet/press-release.pag?docid=275888962</link>
			<pubDate>Tue, 26 Mar 2013 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?docid=275888962</guid>
		</item>
		<item>
			<category>Market Insight</category>
			<title>The Introduction and Impact of ClinicalKey, Elsevier's Clinical Insight Engine</title>
			<description>As a global growth consulting, advisory and research firm, Frost &amp; Sullivan monitors trends in a broad range of healthcare markets to understand the factors that drive the adoption of new IT-led solutions and systems.</description>
			<link>http://www.frost.com/sublib/display-market-insight.do?id=275795236</link>
			<pubDate>Mon, 25 Mar 2013 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/sublib/display-market-insight.do?id=275795236</guid>
		</item>
	</channel>
</rss>